Disciplined Investments’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$250K Buy
1,948
+13
+0.7% +$1.52K 0.08% 126
2026
Q1
$233K Buy
+1,935
New +$223K 0.08% 124
2023
Q3
Sell
-651
Closed -$75.1K 1002
2023
Q2
$75.1K Sell
651
-12
-2% -$1.36K 0.04% 175
2023
Q1
$70.5K Buy
663
+2
+0.3% +$216 0.03% 200
2022
Q4
$73.3K Buy
661
+25
+4% +$2.56K 0.04% 173
2022
Q3
$55K Sell
636
-10
-2% -$893 0.03% 209
2022
Q2
$59K Buy
646
+42
+7% +$3.72K 0.03% 207
2022
Q1
$50K Buy
604
+118
+24% +$9.3K 0.02% 224
2021
Q4
$37K Hold
486
0.02% 242
2021
Q3
$37K Hold
486
0.02% 228
2021
Q2
$38K Sell
486
-50
-9% -$3.72K 0.02% 215
2021
Q1
$39K Hold
536
0.02% 192
2020
Q4
$42K Sell
536
-194
-27% -$14.8K 0.03% 162
2020
Q3
$58K Hold
730
0.04% 148
2020
Q2
$54K Hold
730
0.04% 155
2020
Q1
$54K Hold
730
0.05% 147
2019
Q4
$63K Buy
+730
New +$60K 0.05% 149

Other funds holding MRK

Disciplined Investments's MRK Position: Q2 2026 in Review

Disciplined Investments increased its Merck (MRK) stake by 0.67% in Q2 2026, buying an estimated $1.52K and bringing the position to 1,948 shares worth $250K. The position accounts for 0.08% of the portfolio, ranked #126.

Disciplined Investments first reported a position in MRK in Q4 2019 and has held it in 17 quarters since. 3,819 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Disciplined Investments held 1,948 shares of Merck worth $250K as of Q2 2026.
  • Disciplined Investments bought 13 Merck shares in Q2 2026, an estimated $1.52K.
  • Merck made up 0.08% of Disciplined Investments's portfolio in Q2 2026, its #126 holding.
  • Disciplined Investments first reported a position in Merck in Q4 2019 and has held it in 17 quarters since.
  • 3,819 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Disciplined Investments's 13F filing for Q2 2026, filed 7 Aug 2026.